Kodiak Sciences Capital Expenditures (CapEx) Growth & History (KOD)
Kodiak Sciences's capital expenditures (capex) was $506,000 for fiscal 2025.
View full Kodiak Sciences company overviewKodiak Sciences annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $506,000 | $131,000 | +34.93% |
| 2024 | 2024-12-31 | $375,000 | −$41.0M | −99.09% |
| 2023 | 2023-12-31 | $41.4M | $4.3M | +11.69% |
| 2022 | 2022-12-31 | $37.0M | $20.0M | +117.36% |
| 2021 | 2021-12-31 | $17.0M | $13.2M | +346.57% |
| 2020 | 2020-12-31 | $3.8M | $3.4M | +772.77% |
| 2019 | 2019-12-31 | $437,000 | $359,000 | +460.26% |
| 2018 | 2018-12-31 | $78,000 | −$131,000 | −62.68% |
| 2017 | 2017-12-31 | $209,000 | −$562,000 | −72.89% |
| 2016 | 2016-12-31 | $771,000 | — | — |
Kodiak Sciences quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $352,000 | $219,000 | +164.66% |
| Q1 2026 | 2026-03-31 | $942,000 | $672,000 | +248.89% |
| Q4 2025 | 2025-12-31 | $43,000 | −$81,000 | −65.32% |
| Q3 2025 | 2025-09-30 | $60,000 | −$120,000 | −66.67% |
| Q2 2025 | 2025-06-30 | $133,000 | $84,000 | +171.43% |
| Q1 2025 | 2025-03-31 | $270,000 | $248,000 | +1127.27% |
| Q4 2024 | 2024-12-31 | $124,000 | −$27.4M | −99.55% |
| Q3 2024 | 2024-09-30 | $180,000 | −$46,000 | −20.35% |
| Q2 2024 | 2024-06-30 | $49,000 | −$1.4M | −96.67% |
| Q1 2024 | 2024-03-31 | $22,000 | −$12.1M | −99.82% |
| Q4 2023 | 2023-12-31 | $27.5M | $24.4M | +797.29% |
| Q3 2023 | 2023-09-30 | $226,000 | −$8.0M | −97.27% |
| Q2 2023 | 2023-06-30 | $1.5M | −$6.8M | −82.14% |
| Q1 2023 | 2023-03-31 | $12.2M | −$5.3M | −30.30% |
| Q4 2022 | 2022-12-31 | $3.1M | −$5.4M | −63.68% |
| Q3 2022 | 2022-09-30 | $8.3M | $3.4M | +71.32% |
| Q2 2022 | 2022-06-30 | $8.2M | $5.7M | +224.65% |
| Q1 2022 | 2022-03-31 | $17.5M | $16.2M | +1311.48% |
| Q4 2021 | 2021-12-31 | $8.4M | $6.5M | +330.53% |
| Q3 2021 | 2021-09-30 | $4.8M | $3.2M | +200.50% |
| Q2 2021 | 2021-06-30 | $2.5M | $2.5M | +3573.91% |
| Q1 2021 | 2021-03-31 | $1.2M | $1.1M | +587.22% |
| Q4 2020 | 2020-12-31 | $2.0M | $1.8M | +1180.39% |
| Q3 2020 | 2020-09-30 | $1.6M | $1.4M | +916.46% |
| Q2 2020 | 2020-06-30 | $69,000 | −$50,000 | −42.02% |
| Q1 2020 | 2020-03-31 | $180,000 | $173,000 | +2471.43% |
| Q4 2019 | 2019-12-31 | $153,000 | $131,000 | +595.45% |
| Q3 2019 | 2019-09-30 | $158,000 | $140,000 | +777.78% |
| Q2 2019 | 2019-06-30 | $119,000 | $81,000 | +213.16% |
| Q1 2019 | 2019-03-31 | $7,000 | $7,000 | — |
| Q4 2018 | 2018-12-31 | $22,000 | — | — |
| Q3 2018 | 2018-09-30 | $18,000 | — | — |
| Q2 2018 | 2018-06-30 | $38,000 | — | — |
| Q1 2018 | 2018-03-31 | $0 | — | — |
Kodiak Sciences capital expenditures (capex) trends
Over the last five fiscal years, Kodiak Sciences's capital expenditures (capex) decreased from $3.8M to $506,000, a change of −$3.3M. The latest reported quarter, Q2 2026, shows $352,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kodiak Sciences source filings ↗